Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 3:37 a.m.

    📋 AEGLEA BIOTHERAPEUTICS, INC. (AGLE) - Clinical Trial Update

    Filing Date: 2022-06-02

    Accepted: 2022-06-02 09:03:02

    Event Type: Clinical Trial Update

    Event Details:

    Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Announces Clinical Trial Update Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) provided an update on its clinical development programs. Clinical Development Highlights:
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Regulatory Process
    • Collaboration: Common Stock

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE))
    • CIK: 0001636282
    • Ticker Symbol: AGLE
    • Period End Date: 2022-06-02
    • Document Type: 8-K

Search

News categories